Analysts at TD Cowen started coverage on shares of Crinetics Pharmaceuticals (NASDAQ:CRNX – Get Free Report) in a research note issued on Tuesday, MarketBeat.com reports. The firm set a “buy” rating ...

TD Cowen adjusted its outlook on McDonald's Corporation (NYSE:MCD) shares, raising the price target from $300.00 to $305.00.

TD Cowen lowered the firm’s price target on Lyft (LYFT) to $14 from $16 and keeps a Hold rating on the shares. The firm said 4Q GBs were 1.0% ...

TD Cowen analyst William Katz maintained a Hold rating on Artisan Partners (APAM – Research Report) today and set a price target of $46.00. The ...

TD Cowen began coverage of Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Buy rating, citing the company's strong position in ...

Canada’s telecom sector has been under pressure, but is the operating environment beginning to improve? TD Cowen's Vince ...

Teledyne Technologies Incorporated (NYSE:TDY) today announced that George Bobb, President and Chief Operating Officer, and Jason VanWees, Vice Chairman, will present at the TD Cowen 46th Annual ...

Investing.com -- TD Cowen downgraded Illumina Inc (NASDAQ:ILMN) to "Hold" following the company's fourth-quarter earnings, citing weaker-than-expected next-generation sequencing (NGS) consumable ...

Metagenomi is a precision genetic medicines company committed to developing curative therapeutics for patients using its ...

TD Cowen initiated coverage of KalVista (KALV) with a Buy rating and $30 price target The firm cites sebetralstat’s opportunity as the first oral acute therapy for hereditary angioedema attacks ...

Salesforce has been upgraded to a Buy from TD Cowen analysts, who also raised their price target to $400 per share citing the year-end stock rally tied to the deployment of the Agentforce AI product.